Gabriele Forlani
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · 73 works · 9,193 citations · h-index 27
Top works
- Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
- Association of nonalcoholic fatty liver disease with insulin resistance
- NASH: From liver diseases to metabolic disorders and back to clinical hepatology
- Obesity-Associated Liver Disease
- WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes
- Kidney Function After Improved Metabolic Control in Newly Diagnosed Diabetes and in Diabetic Patients with Nephropathy
- Lipid Abnormalities in Insulin-dependent Diabetic Patients with Albuminuria
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- Cardiovascular Disease in Cirrhosis
- Insulin and glucagon levels in liver cirrhosis
- Insulin-dependent metabolism of branched-chain amino acids in obesity
- Effect of Euglycemic Insulin Infusion on Plasma Levels of Branched–Chain Amino Acids in Cirrhosis
- Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome
- The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
- Branched-chain amino acids and alanine as indices of the metabolic control in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients
- Effects of cognitive–behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder
- Is liver disease a threat to patients with metabolic disorders?
- Effect of long-term near-normoglycemia on the progression of diabetic nephropathy.
- Plasma Exchange in the Management of Patients with Multiple Sclerosis: Preliminary Observations